| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.2 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.06 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.098 | 0.2 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.097 | 0.04 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.04 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.3 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.3 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.075 | 0.4 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |